Lenacapavir offering new hope for HIV prevention?
The United Nations has warned that nearly three million children could contract HIV by 2040, with more than half at risk of dying from AIDS-related illnesses if prevention and treatment efforts are not significantly expanded. The agency says the overwhelming majority of these infections are expected to occur in sub-Saharan Africa, where young people remain disproportionately affected by the epidemic. Amid these concerns, a major scientific breakthrough is offering new hope. Lenacapavir, a long-acting HIV prevention injection administered just twice a year, is being hailed as a potential…
The skinny
The skinny isn't ready yet — notes appear once the transcript is processed.